MarkNtel Advisors recently published a detailed industry analysis of the Global Type-2 Diabetes Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Type-2 Diabetes Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2028

The Type-2 Diabetes Market is projected to grow at a CAGR of around 8.0% during the forecast period, i.e., 2023-28.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Access the detailed PDF Sample report –

https://www.marknteladvisors.com/query/request-sample/global-type-2-diabetes-market.html

What segments define the Global Type-2 Diabetes market from 2023 to 2028? How do these segments contribute to market dynamics and growth?

• By Drug Type
• Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
• Alpha-glucosidase Inhibitors
• Biguanides
• Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
• Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
• Sulfonylureas
• Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)
• By Gender
• Male
• Female

According to report, Between the two, the Women segment held a significant market share in the Global Type-2 Diabetes market in 2022, owing to the alarming rise in the prevalence of type-2 diabetes among pregnant women.

• By Age Group
• Upto 19 years
• 20 – 65 years
• Above 65 years

Explore the Complete Global Type-2 Diabetes Market Analysis Report –

https://www.marknteladvisors.com/research-library/global-type-2-diabetes-market.html

Geographical Analysis: Global Type-2 Diabetes Market

North America

South America

Europe

The Middle East & Africa

Asia-Pacific

Global Type-2 Diabetes Market Share & Competitive Landscape:

The Type-2 Diabetes Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry's leading companies, highlighting their strengths, financial performance, and market influence.

Leading Companies in the Global Type-2 Diabetes Market are:

• Merck & Co
• AstraZeneca
• Novo Nordisk
• Bristol-Myers Squibb
• Eli Lilly
• Sanofi
• Boehringer Ingelheim
• Pfizer
• Takeda
• Biocon
• Johnson & Johnson

Recent Developments in the Global Type-2 Diabetes Market

• In August 2022, AstraZeneca's diabetes drug Farxiga exhibits significant reductions in hospitalization and death risks among patients with all types of heart failure.

• In June 2022, AstraZeneca’s Bydureon BCise, an exenatide 2 mg prolonged-release suspension for injection in a pre-filled pen, has been approved to include in the treatment of type-2 diabetes (T2D) in children and adolescents (10 years and above) in the European Union (EU).

Other reports:

Intelligent Soft Robotics Market

Intelligent Soft Robotics Market Demand

Intelligent Soft Robotics Market Future

Intelligent Soft Robotics Market Growth

Questions Addressed in this Study

1.What factors are driving the Global Type-2 Diabetes Market growth?

2.How is the Global Type-2 Diabetes Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Global Type-2 Diabetes Market?

4.What is the current size of the Global Type-2 Diabetes Market, and how is it projected to change in the future?

6.What is the future outlook for the Global Type-2 Diabetes Market in terms of technological advancements and market expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here –

https://www.marknteladvisors.com/query/request-customization/global-type-2-diabetes-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 |  +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India